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We have cloned genes encoding elongation factors EF-Tu and EF-Ts from Pseudomonas aeruginosa and expressed and purified the
proteins to greater than 95%homogeneity. Sequence analysis indicated thatP. aeruginosaEF-Tu andEF-Ts are 84%and 55% identical
to E. coli counterparts, respectively. P. aeruginosa EF-Tu was active when assayed in GDP exchange assays. Kinetic parameters for
the interaction of EF-Tu with GDP in the absence of EF-Ts were observed to be 𝐾
𝑀
= 33𝜇M, 𝑘obscat = 0.003 s
−1, and the specificity
constant 𝑘obscat /𝐾𝑀 was 0.1 × 10
−3 s−1 𝜇M−1. In the presence of EF-Ts, these values were shifted to 𝐾
𝑀
= 2𝜇M, 𝑘obscat = 0.005 s
−1, and
the specificity constant 𝑘obscat /𝐾𝑀 was 2.5 × 10
−3 s−1 𝜇M−1. The equilibrium dissociation constants governing the binding of EF-Tu
to GDP (𝐾GDP) were 30–75 nM and to GTP (𝐾GTP) were 125–200 nM. EF-Ts stimulated the exchange of GDP by EF-Tu 10-fold.
P. aeruginosa EF-Tu was active in forming a ternary complex with GTP and aminoacylated tRNA and was functional in poly(U)-
dependent binding of Phe-tRNAPhe at the A-site of P. aeruginosa ribosomes. P. aeruginosa EF-Tuwas active in poly(U)-programmed
polyphenylalanine protein synthesis system composed of all P. aeruginosa components.
1. Introduction
Pseudomonas aeruginosa is an opportunistic bacterial path-
ogen and the causative agent in a wide range of infec-
tions, including bacteremia, urinary tract infections, burn
wound infections, and pulmonary infections in patients on
respirators. In the intensive care unit, P. aeruginosa is the
most common Gram-negative pathogen causing infections,
accounting for 10% of all cases. In hospitals, P. aerugi-
nosa is responsible for about one-seventh of all infections,
with multidrug-resistant strains becoming increasingly com-
mon [1, 2]. However, the most serious medical problem
caused by P. aeruginosa is lung infection associated with
cystic fibrosis [3]. The lungs of cystic fibrosis patients are
commonly colonized by P. aeruginosa before ten years of
age, and chronic infections are the most important causes of
morbidity andmortality [4]. Antimicrobial resistance among
clinical isolates of P. aeruginosa is significant and growing [5]
and has become a major problem in hospital patients [6].
Protein synthesis is an essential metabolic process occur-
ring in all bacteria and is a validated target for the devel-
opment of new antibiotics [7, 8]. The components of the
bacterial protein synthesis system are sufficiently different at
the molecular level from those found in eukaryotic cells as
to allow development of compounds that inhibit growth of
bacteria without having adverse effects on eukaryotic cells.
Elongation factor Tu (EF-Tu) plays a central role in protein
biosynthesis by delivering aminoacyl-tRNA (aa-tRNA) to the
A-site of the ribosome during the elongation phase of protein
synthesis [9]. To this end, EF-Tu forms a ternary complex
with GTP and aa-tRNA. The ternary complex binds the A-
site of an actively translating ribosome in amRNA-dependent
manner. Once the cognate ternary complex is bound to the
ribosome, the GTP is hydrolyzed to GDP by activation of
the GTPase activity of EF-Tu [10]. The resulting EF-Tu⋅GDP
complex then dissociates from the ribosome and is recycled
to the active EF-Tu⋅GTP complex in a nucleotide exchange
reaction catalyzed by elongation factor Ts (EF-Ts) [11].
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We have previously developed a poly(U)-directed ami-
noacylation/translation (A/T) high throughput screening
system from E. coli which was used to identify a series of
compounds containing a common scaffold (tetrahydropy-
rido[4,3-d]pyrimidin-4-ol) that inhibited protein synthesis
in a broad spectrum of bacteria [12]. Since P. aeruginosa
is arguably the organism most evolutionarily distant from
E. coli among the major human Gram-negative pathogens,
and given its importance as the causative agent of fatalities
among cystic fibrosis patients, we are developing an A/T high
throughput screening system similar to the E. coli system
but consisting solely of components from P. aeruginosa.
Also, several compounds have recently been identified that
inhibit the activity of EF-Tu in Gram-positive organisms [13,
14]. These findings provided an impetus for us to better
understand the components involved in protein synthesis as
it occurs in P. aeruginosa and provided evidence that other
components besides the ribosome in the protein synthesis
apparatus can be important targets in the development of
antibacterials. We describe here the cloning and enzymatic
characterization of EF-Tu and EF-Ts from P. aeruginosa as
part of the continuing development of a P. aeruginosa A/T
screening system.
2. Methods and Materials
2.1.Materials. Champion pETDirectional TOPOExpression
Kits were from Invitrogen. Plasmids were from Novagen.
Oligonucleotides were from Integrated DNA Technologies
(Coralville, IA,USA). All other chemicals were obtained
from either Sigma Aldrich (St. Louis, MO-) or Fisher Sci-
entific (Pittsburg, PA-). Early log-phase ribosomes from P.
aeruginosa strain PA01 were prepared in the laboratory of
Walter Hill at the University of Montana (Missoula, MT-)
as previously described [15]. DNA sequencing was at the
Howard Hughes Medical Institute (HHMI) laboratory at the
University of Texas-Pan American.
2.2. Gel Electrophoresis andProteinAnalysis. Sodiumdodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was
performed using 4% to 12% (w/v) polyacrylamide precast gels
(Bio-Rad). Benchmark unstained protein molecular weight
markers were from Invitrogen (Madison, WI, USA). Protein
concentrations were determined by the method of Bradford
[16] using Coomassie Protein Assay Reagent (Thermo Scien-
tific) and bovine serum albumin as the standard.
2.3. Cloning and Purification of EF-Tu and EF-Ts. The gene
encoding EF-Tu was amplified by PCR (Bio-Rad MJ Mini
Therma Cycler) from genomic DNA isolated in our labo-
ratory from P. aeruginosa PAO1 (ATCC) using a forward
primer (5󸀠-CACCATGGCTAAAGAAAAATTTGAACG-3󸀠)
which contained the 5󸀠 CACC sequence for insertion into
pET101/D-TOPO directional plasmid and a reverse primer
(5󸀠-TCAATGGTGATGGTGATGGTGAGAACCTTCGAT-
GATCTTGGCAACC-3󸀠) which was designed to add six
histidine amino acid residues to the C terminus of EF-Tu.
The PCR product was inserted into pET101/D-TOPO and
transformed into E. coli Rosetta 2(DE3) Singles Competent
Cells (Novagen). The gene encoding EF-Ts was amplified
from P. aeruginosa genomic DNA using a forward primer
(5󸀠-CTGAGCTAGCGCAGAAATTACTGCAGCCAT-3󸀠)
designed to add an NheI restriction site to the 5󸀠 end of the
gene and a reverse primer (5󸀠-GACTAAGCTTCATTACTG-
CTTGGTGGCGG-3󸀠) which was designed to add a HindIII
restriction site to the 3󸀠 end of the gene. This allowed the
PCRproduct to be placed downstreamon a region containing
a sequence encoding six histidine amino acid residues.
The PCR product was inserted between the NheI/HindIII
restriction sites in pET-28b(+) (Novagen) and transformed
into Rosetta 2(DE3) Singles Competent Cells. All primers
were designed from P. aeruginosa complete genome sequence
listed on the National Center for Biotechnology Information
website (NC 002516.2).
Cultures were grown in F-medium [17] containing 50𝜇g/
mL of ampicillin and 75 𝜇g/mL of chloramphenicol at 37∘C.
Expression of the target proteins was induced at an optical
density (A
600
) of 0.6 by the addition of isopropyl 𝛽-D-
1-thiogalactopyranoside (IPTG) to 0.5mM. Growth of the
bacterial culture was continued for 1.5 h after induction,
and the bacteria were harvested by centrifugation (4000×g,
60min, 4∘C).The cells were lysed, and fraction Iwas prepared
as previously described [17]. P. aeruginosa EF-Tu precipitated
with proteins between 45%and60% saturation of ammonium
sulfate, and the precipitated proteinwas collected by centrifu-
gation (23,000×g, 60min, 4∘C). EF-Tu was further purified
to more than 98% homogeneity using nickel-nitrilotriacetic
acid (NTA) affinity chromatography (Perfect Pro, 5 Prime).
The column (1mL) was washed with buffer A (20mMHepes
(pH 7.0), 40mM KCl, 1mM MgCl
2
, 0.1mM EDTA, 10%
Glycerol) containing 1M NaCl, and 20mM imidazole, and
the target protein was eluted in buffer A containing 200mM
imidazole. Elution of the proteinwas followedby dialysis (two
times) against buffer A. Purified proteins were fast frozen
in liquid nitrogen and stored at −80∘C. P. aeruginosa EF-
Ts did not precipitate in ammonium sulfate concentrations
below 60% saturation, and the supernatant from the 60%
saturated ammonium sulfate sample was used for the further
purification of EF-Ts using NTA affinity chromatography as
described earlier for EF-Tu. EF-Ts was purified to greater than
95% homogeneity.
2.4. Determination of the Concentration of GDP in P. aerugino-
sa EF-Tu Preparations. Theconcentration ofGDP inP. aerug-
inosa EF-Tu preparations was determined by absorbance
spectroscopy. Samples of EF-Tu preparations (250𝜇L, 37 𝜇M)
and controls (dialysis buffer) were denatured at 90∘C for
10min.The denatured samples were centrifuged in an Eppen-
dorf centrifuge for 30min at 4∘C to remove the precipitated
protein. The absorbance spectra of the supernatants con-
taining released GDP were then measured using the dialysis
buffer control as the background. The concentrations of
GDP were measured by the absorbance at 260 nm using an
extinction coefficient of 13,804M−1 cm−1 [18].
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2.5. Aminoacylation of tRNA𝐿𝑒𝑢 and tRNA𝑃ℎ𝑒. tRNALeu
was aminoacylated in 2.5mL reactions containing 50mM
Tris-HCl, (pH 7.5), 5mM MgOAc, 2.5mM ATP, 90𝜇M
crude E. coli tRNA (approximately 7 𝜇M tRNALeu ), 50𝜇M
[3H]leucine (60 cpm/pmol), and 0.8 𝜇M P. aeruginosa leucyl-
tRNA synthetase (previously purified in our laboratory).
tRNAPhe was aminoacylated in 2.5mL reactions containing
50mM Tris-HCl, (pH 7.5), 5mMMgCl, 2.5mM ATP, 90𝜇M
crude E. coli tRNA (approximately 2 𝜇M tRNAPhe), 50𝜇M
[3H]phenylalanine (75 cpm/pmol), and 1.4𝜇M P. aeruginosa
phenyl-tRNA synthetase (previously purified in our labora-
tory). Both aminoacylation reactions were incubated at 37∘C
for 1.5 h. The tRNA was then collected by precipitation with
ethanol followed by centrifugation (30,000×g, 45min, 4∘C)
and resuspended in 0.5mL of 10mM Tris-HCl, (pH 7.5).
2.6. Determination of GDP Exchange by EF-Tu and of the
Ability of EF-Ts to Stimulate This Exchange. Nitrocellulose
filter binding assayswere used to determineGDPexchange by
EF-Tu as previously described [19, 20]. Assays to determine
the initial velocity of GDP exchange were in buffer B (50mM
Tris-HCl, (pH 7.5), 50mM NH
4
Cl, and 10mM MgCl
2
,
1.0mM dithiothreitol (DTT)) containing 12𝜇M [3H]GDP
(500 cpm/pmol). Reactions were incubated at 37∘C and were
stopped by diluting the reaction mix to 2mL in buffer B
and immediately filtered through nitrocellulose (Whatman;
Protran BA 85). Filters were washed three times with 2mL
of buffer B and allowed to dry, and the amount of EF-
Tu⋅[3H]GDP complex retained was determined by scintilla-
tion counting (Beckman Coulter LS 6500). Initial velocity
reactions were from 1 to 4min, andGDP concentrations were
varied as indicated. Initial velocity assays containing EF-Ts
were assayed at reactions times between 15 and 75 s, and the
concentration of EF-Ts was held constant at 0.01𝜇M, while
GDP concentrations were varied as indicated.
EF-Ts stimulates the exchange of GDP bound by EF-Tu.
Nitrocellulose binding assays used to determine EF-Ts stim-
ulation of GDP exchange were the same as those described
earlier with the following changes: GDPwas reduced to 1𝜇M,
EF-Tu was held constant at 0.64𝜇M, and EF-Ts was added to
0.05𝜇M (1 : 13 EF-Ts to EF-Tu ratio), and the reaction times
for the assays were decreased from 30min to 15 to 120 s.
2.7. Equilibrium Dissociation Constants for the EF-Tu⋅GDP
and EF-Tu⋅GTP Complexes. Reactions were carried out to
determine the equilibrium dissociation constants (𝐾GDP and
𝐾GTP) for the interaction of P. aeruginosa EF-Tu with GDP
and GTP. The reaction was carried out in buffer B contain-
ing 1.3 𝜇M total P. aeruginosa EF-Tu and 12 𝜇M [3H]GDP
(500 cpm/pmol) or [3H]GTP (750 cpm/pmol). EF-Ts was
added to 0.05 𝜇M as indicated. To form EF-Tu⋅nucleotide
complexes, the reactions were incubated for 2 h at 0∘C. To
determine the total amount of complex formed (defined as
active amounts of EF-Tu), reactions were immediately filtered
through nitrocellulose filters following incubation. Reactions
to determine 𝐾GDP and 𝐾GTP were diluted by the addition
of 5mL of buffer B that had been preincubated at 37∘C,
23∘C, or 0∘C. Incubationwas continued at those temperatures
after dilution for 10, 20, and 30min, respectively. Remaining
amounts of the complexes were determined by filtration
through nitrocellulose filters.
2.8. EF-Tu Ternary Complex Formation and Phe-tRNA𝑃ℎ𝑒
Delivery to the Ribosome. Ternary complex formation was
assayed by examining the ability of EF-Tu to protect [3H]Leu-
tRNALeu ) from digestion by RNase A [21, 22]. EF-Tu (0,
0.6, 0.9, 1.2, 1.5, 1.8, 2.1, and 2.4𝜇M) was incubated in reac-
tion mixtures (50 𝜇L) containing 1.2 𝜇M [3H]Leu-tRNALeu,
0.5mM GTP, 50mM Tris-HCl, (pH 7.5), 1mM DTT, 50mM
NH
4
Cl, and 6.5mM MgCl
2
for 15min at 4∘C. RNAase A
was then added to a final concentration of 0.02mg/mL and
incubated for an additional 20 s. The reactions were stopped
by the addition of 3mL of ice-cold 5% trichloroacetic acid
(TCA) and filtered through nitrocellulose filters (Whatman).
Retention of [3H]Leu signified EF-Tu protection of [3H]Leu-
tRNALeu from nuclease digestion [22].
To determine ternary complex binding to the ribosome,
a mixture containing 50mM Tris-HCl, (pH 7.5), 0.1mM
spermine, 40mM KCl, 4mM MgCl
2
, 1.0mM DTT, 0.3mM
GTP or guanosine 5󸀠-[𝛽,𝛾-imido]triphosphate (GDPNP),
0.15mg/mL poly(U) mRNA, 0.06𝜇M P. aeruginosa EF-
Ts, 3.2 𝜇M EF-Tu, 1.0 𝜇M P. aeruginosa ribosomes, and
0.75 𝜇M [3H]Phe-tRNAPhe (25 cpm/pmol) was used. The
concentration of EF-Tu was varied from 0.32 to 1.6𝜇M
as indicated. All components were preincubated at 37∘C
for 15min in the absence of ribosomes to allow ternary
complex formation. Ribosomes were then added, and incu-
bation was continued for an additional 15min at the same
temperature. The amounts of [3H]Phe-tRNAPhe bound to
the ribosome, representing ternary complex, were analyzed
using glassmicrofiber filter (Whatman) binding as previously
described [23]. Control reactions lacked either EF-Tu or
ribosomes.
2.9. EF-Tu Functions in Protein Synthesis. Protein synthe-
sis assays were carried out in 50𝜇L reactions containing
50mM Tris-HCl, (pH 7.5), 10mMMgCl
2
, 25mMKCl, 4mM
phosphoenolpyruvate (PEP), 0.025U/mL pyruvate kinase
(PK), 1.5mM ATP, 0.5mM GTP, 40 𝜇M [3H]phenylalanine
(75 cpm/pmol), 0.3mg/mL poly(U) RNA, 0.03mM sper-
mine, 1mM DTT, 0.05𝜇M P. aeruginosa elongation factor-
Ts (EF-Ts), 0.2 𝜇M P. aeruginosa elongation factor-G (EF-G),
0.1 𝜇M P. aeruginosa phenylalanyl-tRNA synthetase (PheRS),
0.2 𝜇M P. aeruginosa ribosomes, and the indicated amounts
of P. aeruginosa EF-Tu. Reactions were started by the addition
of E. coli tRNA to a final concentration of 0.5 𝜇M tRNAPhe
and continued for 1 h at 37∘C. Reactions were stopped by the
addition of 2mL 10% (w/v) TCA and filtered through glass
fiber filters (Whatman) as previously described [23]. Reten-
tion of [3H]Phe represents the amount of polyphenylalanine,
poly (Phe), synthesized.
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Table 1: Percent identity between P. aeruginosa EF-Tu and EF-Ts and the corresponding factors from other organisms.
Species Evolutionary group EF-Tu EF-Ts
Rickettsia rickettsii Proteobacteria; Alphaproteobacteria 77 38
Neisseria gonorrhoeae Proteobacteria; Betaproteobacteria 79 43
Bdellovibrio bacteriovorus Proteobacteria; Deltaproteobacteria 75 40
Helicobacter pylori Proteobacteria; Epsilonproteobacteria 74 32
Campylobacter jejuni Proteobacteria; Epsilonproteobacteria 72 31
Escherichia coli Proteobacteria; Gammaproteobacteria 84 55
Haemophilus influenzae Proteobacteria; Gammaproteobacteria 82 49
Chlamydia trachomatis Chlamydiales/Verrucomicrobia group 67 29
Corynebacterium jeikeium Actinobacteria 68 35
Mycobacterium tuberculosis Actinobacteria 72 31
Staphylococcus aureus Firmicute; Bacilli; Bacillales 73 45
Streptococcus pneumoniae Firmicute; Bacilli; Lactobacillales 68 35
Clostridium difficile Firmicutes; Clostridia 73 45
𝐻𝑜𝑚𝑜 𝑠𝑎𝑝𝑖𝑒𝑛𝑠
1 Eukaryota; Opisthokonta; Metazoa 26 12
Saccharomyces cerevisiae Eukaryota; Opisthokonta; Fungi 26 14
Homo sapiensmitochondrial Eukaryota; Opisthokonta; Metazoa 37 19
1The protein corresponding to P. aeruginosa EF-Tu in eukaryotic cells is EF-1𝛼, and the protein corresponding to EF-Ts that was used in the sequence analysis
is EF-1𝛽.
3. Results
3.1. Sequence Analysis. The translation elongation factors EF-
Tu and EF-Ts previously studied have primarily been those
from E. coli (and a few other bacteria) and from mammalian
mitochondria and to amuch lesser extent from the eukaryotic
cytoplasm [24, 25]. We analyzed the similarity between P.
aeruginosa EF-Tu and EF-Ts and their homologs from other
groups of organisms (Table 1). When compared with other
Gram-negative bacteria (primarily from the phylum Pro-
teobacteria), P. aeruginosa EF-Tu residues were observed to
be highly conserved, with the percentage of identical residues
ranging from 72% to 84%. However, the level of homology
of P. aeruginosa EF-Ts with the same organisms ranged
from only 31% to 55% identical residues. When compared
with members of the Chlamydiales, Actinobacteria, and
Gram-positive Firmicutes, the percent of identical residues
did not differ significantly from that observed with the
Gram-negative bacteria for both EF-Tu (67% to 73%) and
EF-Ts (29% to 45%). However, when P. aeruginosa EF-Tu
was compared to eukaryotic cytoplasmic EF-Tu (EF1𝛼), the
percent identity is only 26%, and when compared to the
mitochondrial counterparts the homology was 37% identical
residues. P. aeruginosa EF-Ts had negligible homology to
eukaryotic EF-Ts (EF-1𝛽). For the pursuit of compounds that
specifically inhibit the activity of bacterial EF-Tu or EF-Ts, the
lack of homology with eukaryotic homologs is an advantage.
The crystal structures of E. coli EF-Tu reveal that
the protein folds into a three-dimensional structure com-
posed of three domains connected by highly flexible spacer
peptides [26, 27]. The N-terminal 200 amino acids are
encompassed within domain I which contains the guanine
nucleotide binding site and the catalytic site for the GTPase
activity. The functions of domain II (residues 208–295, E.
coli numbering) and domain III (residues 300–393) are
less well understood, but domains I and III interact with
EF-Ts, while all three domains are involved in aa-tRNA
binding [26, 28, 29]. Sequence comparisons show that EF-
Tu from P. aeruginosa is 84% identical to EF-Tu from E. coli
(Figure 1(a)). The primary region of amino acid sequence
divergence appears to be within the region just N-terminal
to the spacer connecting domains I and II. This region of
sequence divergence is also observed in a larger alignment
[10] of EF-Tumolecules fromGram-negative organisms (data
not shown).
In contrast to the comparison for EF-Tu, the primary
sequence of P. aeruginosa EF-Ts is only 55% identical to that
of its E. coli homolog. Figure 1(b) shows the high degree of
divergence between E. coli and P. aeruginosa EF-Ts. However,
the N-terminal and C-terminal modules of EF-Ts appear
to contain more conserved residues than the other regions.
These regions interact with nucleotide binding domain I of
EF-Tu (which is highly conserved) [26, 30]. Residues Asp-
80, Phe-81, and Gly-126 and residues surrounding Ile-125 in
subdomain N of the core region (amino acid residues that
interact directly with residues in domain I of EF-Tu) are
conserved between E. coli and P. aeruginosa EF-Ts. The core
region contains a lesser degree of conserved residues. How-
ever, subdomain C located within the core region contains
conserved residuesHis-147, Ile-151, Lys-166,Met-170, Ala-174,
and Val-234 (E. coli numbering) that directly interact with
amino acid residues in domain III of EF-Tu [26]. Residues
180–228 (E. coli numbering) contain the smallest amount
of conserved residues and are contained within a plausible
dimerization module of EF-Ts [26]. This region interacts
with the same region of an identical EF-Ts in the proposed
EF-Tu⋅EF-Ts dimer; thus, the low conservation of residues
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Figure 1: Alignment of P. aeruginosa EF-Tu and EF-Ts with E. coli homologs. (a) Alignment of E. coli and P. aeruginosa EF-Tu. Black
background indicates conserved residues. (b) Alignment of E. coli and P. aeruginosa EF-Ts. The four structural modules are labeled. The
asterisk indicates the residue of the strictly conserved TDFV sequence that contains a variant residue in all Pseudomonas sp. EF-Ts proteins.
here is consistent with low homology between diverse EF-
Ts molecules from various organisms. However, when this
region is compared with the same regions from other mem-
bers of the Pseudomonas genus, P. mendocina, P. putida, P.
fluorescens, and P. syringae, it is highly conserved (data not
shown). A unique feature was noted within the sequence
of P. aeruginosa EF-Ts that involved the highly conserved
TDFV motif which acts to displace the Mg2+ in the GTPase
center of EF-Tu [31]. In all organisms analyzed, this motif
contains Thr-Asp-Phe-Val at positions 79–82 (E. coli EF-Ts
numbering). However, in EF-Ts from all of the Pseudomonas
strains listed earlier, the valine was replaced with a leucine.
The addition of a methyl group to the side chain would seem
to be a modest change, and in the structures of E. coli EF-
Tu⋅EF-Ts [26], Thermus thermophilus EF-Tu⋅EF-Ts [30], and
mammalian mitochondrial EF-Tu⋅EF-Ts [31], there appears
to be room to accommodate an additional methyl group at
this position. It is interesting that this change is only observed
in Pseudomonas.
3.2. Expression andPurification of P. aeruginosa EF-Tu andEF-
Ts. Thegene encodingP. aeruginosaEF-Tswas PCRamplified
and inserted into pET-28b(+) (Novagen). This allowed the
protein to be expressed fused to an N-terminal peptide
containing a 6-histidine tag for ease of purification. The
gene encoding P. aeruginosa EF-Tu was PCR amplified and
inserted into pET101/D-TOPO (Invitrogen) fused to a C-
terminal sequence containing a 6-histidine tag. The DNA
sequence of both constructs was confirmed byDNA sequenc-
ing, and the plasmids were transformed into Rosetta 2(DE3)
(Novagen). Both proteins were expressed in a soluble form,
with P. aeruginosa EF-Ts comprising approximately 30–40%
of the total protein and P. aeruginosa EF-Tu appearing to have
similar expression as the native E. coli EF-Tu (approximately
10% of total protein) but shifted 1 kDa due to the additional
amino acid residues in the fusion peptide. The proteins
were purified using Ni-NTA resin technology. EF-Tu was
purified to approximately 98% homogeneity and EF-Ts to
approximately 95%homogeneity (Figure 2). A contaminating




Figure 2: SDS-PAGE analysis of purified P. aeruginosa EF-Ts and
EF-Tu. Samples (1.0 and 0.5 𝜇g, resp.) of the P. aeruginosa EF-Ts and
EF-Tu preparations were analyzed on a 4–20% (w/v) SDS-PAGE gel,
and the protein bands were visualized by staining with Coomassie
blue.
protein in the EF-Ts preparation shown in Figure 2 was
observed just above the position of P. aeruginosa EF-Tu.
The masses of E. coli and P. aeruginosa (plus the fusion
peptide) EF-Tu are 43311 kDa and 44267 kDa, respectively,
indicating that the contaminating protein was not E. coli
EF-Tu. Since recombinant EF-Ts, in particular mitochondrial
EF-Ts [32], can bind tightly to the endogenous EF-Tu when
overexpressed in E. coli, copurificationmay sometimes occur.
To test whether residual E. coli EF-Tu was present in the EF-
Ts preparation, the GDP exchange assay was used to monitor
GDP exchange when only EF-Ts was present in the assay. No
GDP binding was observed in these assays (data not shown)
indicating that the preparations of EF-Ts used here were free
of EF-Tu.
3.3. Ability to Exchange Guanine Nucleotides. During purifi-
cation of E. coli EF-Tu the nucleotide GDP is copurified
bound to EF-Tu [33]. Previous analysis indicated that unless
EF-Tu is subjected to extensive dialysis (3 days) in the absence
of Mg++, GDP remains bound to the purified EF-Tu [34].
To ascertain if P. aeruginosa EF-Tu was purified bound to
GDP, samples of EF-Tu were heat denatured and precipitated
and the concentration of released GDP remaining in solution
was measured by absorbance spectroscopy [35]. From these
experiments, the ratio of EF-Tu to GDP was calculated to be
at a 1 : 1 ratio, indicating that in fact GDP remained bound to
P. aeruginosa EF-Tu during the purification process (data not
shown).
The percentage of EF-Tu capable of exchanging GDP
(active EF-Tu) was determined from assays described in
Section 3.6 which measured the total EF-Tu⋅[3H]GDP com-















Figure 3: Assays to determine the ability of EF-Ts to stimulate
GDPexchange by EF-Tu were as described under Section 2. The
concentration of EF-Tu was held at 0.64𝜇M. EF-Ts concentrations
were 0.05 𝜇M (1 : 13 EF-Ts to EF-Tu ratio) when present, and the
reaction times for the assays ranged from 15 to 120 s. Activity is
the amount of [3H]GDP (1500 cpm/pmol) bound by EF-Tu. EF-Tu
exchange activity in the presence (∙) and absence (◼) of EF-Ts.
[3H]GDP (12 𝜇M) were incubated with EF-Tu on ice for 2 h,
and the total labeled EF-Tu⋅[3H]GDP complex was deter-
mined using nitrocellulose filter binding, which retained
the complex but not free GDP. The maximum amount
of EF-Tu⋅GDP complex observed would be equivalent to
the concentration of EF-Tu capable of exchanging GDP.
Approximately 50% of EF-Tu was capable of forming an
EF-Tu⋅[3H]GDP complex. In the subsequent experiments
containing EF-Tu, the results were based on the concentration
of active EF-Tu.
3.4. Stimulation of EF-Tu by EF-Ts. The catalytic function
of EF-Tu is facilitated by EF-Ts which promotes guanine
nucleotide exchange. In E. coli, EF-Ts promotes the release of
GDP from EF-Tu⋅GDP complex thereby forming an interme-
diate EF-Tu⋅Ts complex [11, 36]. In the absence of GTP and
the aminoacylated tRNA, the EF-Tu⋅Ts complex dissociates
to reform the EF-Tu⋅GDP complex [34, 37]. To determine the
effect of EF-Ts on GDP exchange in the P. aeruginosa system,
we measured GDP exchange by EF-Tu in the presence and
absence of EF-Ts. In reactions containing EF-Ts, the ratio
of EF-Ts to EF-Tu was 1 : 13, respectively, which is near the
physiological ratio [38]. The reactions were stopped at 15 s
intervals between 15 and 120 s. The average GDP exchanged
in the presence of EF-Ts was observed to be 7- to 8-fold
greater than that in the absence of EF-Ts (Figure 3). This is
similar to the stimulation of EF-Tu by EF-Ts seen in the E.
coli system [32].
3.5. Examination of Initial Velocity for Interaction of EF-
Tu with GDP. Historically, the GDP exchange assay has
been used to determine the activity of EF-Tu [20]. From the
studies described earlier and elsewhere [32, 34, 39, 40], it
is known that EF-Ts catalyzes the exchange of GDP by EF-
Tu. The concentration of GDP in cells is low compared to

































Figure 4: Determination of kinetic parameters for the interaction of EF-Tu with GDP in the absence of EF-Ts. (a) Initial velocities for P.
aeruginosa EF-Tu in GDP exchange reactions were determined at various concentrations of GDP. The concentration of EF-Tu was held
constant at 0.64 𝜇M. The velocities were measured between 1 and 4min to minimize the chance of measurement of exchange occurring
during mixing but before the beginning of the incubation period. The concentrations of GDP were ◼, 4 𝜇M; ⃝, 6𝜇M; 󳵳, 8𝜇M; ⧫, 10𝜇M; ∙,
12𝜇M. (b) The data from the initial velocity experiments were used to develop a Lineweaver-Burk plot to determine kinetic parameters for

































Figure 5: Determination of kinetic parameters for the interaction of EF-Tu with GDP in the presence of EF-Ts. (a) Initial velocities for
P. aeruginosa EF-Tu in GDP exchange reactions were determined at various concentrations of GDP. The concentration of EF-Tu was held
constant at 0.64 𝜇M, and the concentration of EF-Tswas held at 0.01𝜇M.The velocities weremeasured between 15 and 75 s.The concentrations
of GDP were ◼, 0.4 𝜇M; ⃝, 2𝜇M; 󳵳, 4𝜇M; ⧫, 8𝜇M; ∙, 12𝜇M. (b)The data were used to develop a Lineweaver-Burk plot to determine kinetic
parameters for the interaction of P. aeruginosa EF-Tu with GDP in the presence of EF-Ts.
the concentration of GTP [38, 41]; thus, it was of interest to
determine the kinetic parameters governing the interaction
of EF-Tu with GDP both in the presence and absence of EF-
Ts. The initial rate of GDP exchange was measured between
1 and 4min in the absence of EF-Ts (Figure 4(a)). The
kinetic parameters 𝐾𝑀 and 𝑉max for the interaction of P.
aeruginosaEF-TuwithGDPwere determined by inserting the
initial velocity data into Lineweaver-Burk plots (Figure 4(b)).
Alternatively, the kinetic parameters were also determined
for the interaction of P. aeruginosa EF-Tu with GDP in the
presence of EF-Ts. In these assays, the incubationwas lowered
to times between 15 and 75 s to compensate for the increased
rate of the exchange process (Figure 5(a)). Determination
of 𝐾𝑀 and 𝑉max values for GDP exchange was carried
out at a constant concentration of EF-Tu (0.64𝜇M) in all
assays, and the concentration of EF-Ts was 0.01𝜇M when
present (Figure 5(b)). The 𝐾𝑀 for the interaction of EF-Tu
with GDP in the absence of EF-Ts was 33 𝜇M. We observed
a shift of the 𝐾𝑀 to 2𝜇M when EF-Ts was added to
the reaction. Since this is not a true enzymatic reaction
(the reaction does not yield an actual product), we hesitate
to address other kinetic parameters such as 𝑘cat and the
specificity constant 𝑘cat/𝐾𝑀 for the interaction. However,
previous work has shown that the exchange of GDP by EF-Tu
follows first-order kinetics when the concentration of GDP is
significantly elevated above the enzyme concentration [37].
GDP was present in the initial velocity assays at various
concentrations to as high as 20-fold and 250-fold above EF-Tu


















Figure 6: The ability of P. aeruginosa EF-Tu to form a ternary
complex with aminoacylated tRNA and GTP. Ternary complex
formation was analyzed by the ability of EF-Tu to protect [3H]Leu-
tRNALeu from digestion by RNase A as described under Section 2.
Background activity was subtracted to show only ternary complex
formed.
and EF-Ts concentrations, respectively. Therefore, the data
which was derived from these experiments yields indirect
information on the individual rate constants for the exchange
of GDP, and the 𝑘cat calculated is the observed 𝑘cat. The 𝑘obscat
for exchange of GDP by P. aeruginosa EF-Tu is 0.003 s−1
and 0.005 s−1 in the absence and presence of EF-Ts. The
specificity constant 𝑘obscat /𝐾𝑀 is 0.1 × 10
−3 s−1 𝜇M−1 and 2.5 ×
10−3 s−1 𝜇M−1 for EF-Tu in the absence and presence of EF-Ts.
The specific activity for the exchange ofGDPbyEF-Tuwas 4.7
× 10−3 𝜇mol/min/mg in the absence of EF-Ts. This is almost
identical to the specific activity of E. coli EF-Tu [33].
There have been numerous studies analyzing the effect
that EF-Ts has on the exchange of GDP by EF-Tu; however,
few studies have directly addressed the catalytic param-
eters of EF-Ts [37, 39, 42]. In the study by Hwang and
Miller [39], E. coli EF-Ts catalyzed exchange rates were
5.9–6.2 pmol/min/units of EF-Ts. Assuming the difference
between the maximum velocities of EF-Tu in the presence
and absence of EF-Ts to be the velocity of EF-Ts, then the
turnover number (𝑘obscat ) for EF-Ts can be predicted. The 𝑘
obs
cat
for P. aeruginosa EF-Ts was 0.02 s−1 resulting in a specific
activity of 686𝜇mol/min/mg.
3.6. Determination of the Equilibrium Dissociation Constants
of EF-Tu⋅GDP and the EF-Tu⋅GTP Complexes. The equilib-
rium dissociation constants for the EF-Tu⋅GDP (𝐾GDP) and
EF-Tu⋅GTP (𝐾GTP) complexes were calculated from mea-
surements of the extent of dissociation of the complexes in
dilute solutions. Both complexes were formed by incubation
at 4∘C for 2 h in 50𝜇L reactions (Section 3.3). In these
assays, approximately 50% of EF-Tu was observed to form
a complex with each form of the nucleotide. To determine
dissociation, the 50𝜇L reactions were diluted by addition of
5mL of reaction mix (minus enzyme and nucleotide) that
had been preincubated to 37∘C, 23∘C, or 0∘C, and incubation
was continued at these temperatures for 10, 20, and 30min,
respectively. These were the conditions used to determine
the 𝐾GDP for interaction of E. coli EF-Tu with GDP, and we
maintained the same conditions in the determination of the
𝐾GTP.
The concentration of complex immediately after dilution
was approximately 6.0 × 10−3 𝜇M. After incubation, the
remaining EF-Tu⋅GDP complex was determined. Total GDP
was calculated as the amount of added [3H]GDP plus GDP
that had copurified with EF-Tu. Free GDP was the amount
of total GDP minus complexes formed, and free EF-Tu was
the amount of initial complexminus remaining complex.The
equilibrium dissociation constants for the complexes were
calculated using the following equation:
𝐾GD/TP =
[EF − Tufree] [GD/TPfree]
[EF − Tu ⋅ GD/TP]
. (1)
We observed 𝐾GDP values for EF-Tu that ranged from 30
to 75 nM in the absence of EF-Ts at the temperatures in
which the EF-Tu⋅GDP complex was allowed to dissociate
(Table 2). Previous studies to determine the 𝐾GDP governing
the binding of GDP to EF-Tu in the E. coli system included
EF-Ts in the assays [33, 43], and therefore we also carried
out assays to determine the 𝐾GDP in the presence of EF-Ts.
There was no statistical change of the 𝐾GDP observed in the
presence of EF-Ts (30 to 40 nM). These values are within 3-
fold of that seen in the E. coli system in which the equilibrium
dissociation constant (5 to 10 nM) was determined in the
presence of EF-Ts [33].
For determination of the equilibrium dissociation con-
stants for binding of GTP to EF-Tu the same procedure
was used. The 𝐾GTP values for EF-Tu were observed to be
between 125 and 200 nM in the presence or absence of EF-
Ts at the temperatures in which the EF-Tu⋅GTP complex was
allowed to dissociate (Table 3). When the 𝐾GTP and 𝐾GDP
for binding each form of the nucleotide are compared, it
becomes apparent that binding ofGTPbyP. aeruginosaEF-Tu
is up to 6-fold weaker than binding of GDP.
3.7. Ability of EF-Tu to Form a Ternary Complex and Mediate
tRNA Binding to the Ribosome. EF-Tu binds aminoacyl-
tRNA and GTP to form a ternary complex, and the aminoa-
cylated tRNA is delivered to the ribosome in this form. As
a result, for EF-Tu to be functional in protein synthesis, it
must be active in ternary complex formation. In E. coli, the
conformation of EF-Tu in the ternary complex is different
than when EF-Tu is bound to either EF-Ts or GDP. The large
opening observed between the domains which is seen when
EF-Tu is bound to EF-Ts or GDP is closed when EF-Tu is
bound to GTP in the ternary complex [44]. To determine
the ability of P. aeruginosa EF-Tu to form a ternary complex
with Leu-tRNALeu and GTP, the nuclease protection assay
was used [19, 22].The nuclease protection assaymeasures the
formation of a ternary complex by the ability of EF-Tu to
protect the 3󸀠 end of the tRNA with the covalently attached
[3H]Leu from digestion by RNase A [45]. [3H]Leu-tRNALeu
was used because the concentration of Leu-tRNA in crude E.
coli tRNA is approximately four times greater thanPhe-tRNA,
allowing a larger percent of the total tRNA to be charged.
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Figure 7: The ability of P. aeruginosa EF-Tu to deliver Phe-tRNAPhe to the ribosome in poly(U)-dependent reactions. (a) Requirement of
components for binding [3H]Phe-tRNAPhe to the ribosome as described under Section 2. Reactions contained 1 𝜇M (50 pmol) ribosome,
0.75 𝜇M [3H]Phe-tRNAPhe (37.5 pmol, 25 cpm/pmol), and 3.2 𝜇M EF-Tu. (b) Reactions were as in “A” except that P. aeruginosa EF-Tu was
varied from 0.32 to 1.6𝜇M in the reactions.The “tRNA bound” refers to the amount of [3H] Phe-tRNAPhe bound to the ribosome. Background
activity (minus EF-Tu) was subtracted to show only EF-Tu promoted A-site binding.














1.3 1.2 4.5 0.5 37 34
1.2 1.2 4.6 0.5 23 30
1.5 1.2 4.2 0.5 0 43
1.5 1.2 2.5 0 37 72
1.0 1.2 3.2 0 23 38
1.3 1.2 2.7 0 0 58
1EF-Tufree and GDPfree as described under Section 3.6.
Reactions contained enough RNase A to hydrolyze over
90% of the leucine away from tRNALeu . EF-Tu was titrated
into the assay, and the amount of Leu-tRNALeu protected
from digestion by RNase A increased in a linear fashion
indicating that P. aeruginosa EF-Tu was active in ternary
complex formation (Figure 6). Up to 20% of the EF-Tu was
active in ternary complex formation under the conditions
used. This is similar to that observed with E. coli EF-Tu [19].
Aminoacylated tRNA is bound at the ribosomal A-site
in a ternary complex [20]. The amount of aminoacylated
tRNAs that can be bound to the A-site of the ribosome in
a ternary complex was measured using [3H]Phe-tRNAPhe in
poly(U)-dependent assays. In the absence of poly(U), a basal
level of ternary complex will bind to the ribosome [20]. In
these assays, GTP was replaced with the nonhydrolyzable
analog GDPNP to prevent hydrolysis of the nucleotide
and dissociation of EF-Tu. As shown in Figure 7(a), EF-
Tu promoted binding of the ternary complex to the A-site
of approximately 50% of the ribosomes within 15min. This
corresponds to approximately 90% of the ternary complex
formed. Removal of EF-Tu or ribosomes in control reactions
resulted in approximately 75% and 90% decrease of the
signal, respectively. As the concentration of EF-Tu present
in the reaction was increased, the binding of the ternary
complex to the ribosome increased (Figure 7(b)), and this
linear relationship shows the requirement for EF-Tu.
3.8. Ability of EF-Tu to Function in Poly(U)-Programed Pro-
tein Synthesis. An aminoacylation/translation (A/T) system
composed of P. aeruginosa protein synthesis components has
been developed in our laboratory. To determine the ability of
EF-Tu to function in protein synthesis, it was titrated into the
assay between 0.25 and 3.0 𝜇M (Figure 8). EF-Tu displayed
robust activity in polypeptide synthesis. The activity of P.
aeruginosa EF-Tu is similar to the activity that is seen with
E. coli EF-Tu in an identical A/T assay with cognate E. coli
protein synthesis components [12].
4. Discussion
We have described here the cloning and characterization
of EF-Tu and EF-Ts from P. aeruginosa that will be used
in construction of an A/T system for use in screening for
antibacterial compounds. EF-Tu has a number of functions
in protein synthesis [25, 26]. EF-Tu has to (1) function
in nucleotide (GDP/GTP) binding, (2) interact with EF-Ts
10 BioMed Research International













4.2 1.2 2.6 0.5 37 190
3.5 1.2 3.3 0.5 23 125
3.9 1.2 2.9 0.5 0 156
4.1 1.2 2.7 0 37 175
3.5 1.2 3.3 0 23 123



















Figure 8: The ability of P. aeruginosa EF-Tu to function in poly(U)-
directed protein synthesis. The assays were as described under
Section 2. Concentrations of EF-Tu were varied between 0.25 and
3.0 𝜇M, and concentrations of ribosomes were held constant at
0.2 𝜇M. “Phe Incorporated” represents the amount of phenylalanine
incorporated into peptides during protein synthesis.
to move between the inactive GDP-bound form and the
active GTP-bound form, (3) bind aminoacylated tRNA and
GTP to form a ternary complex, and (4) be able to deliver
the aminoacylated tRNA to the ribosome during protein
synthesis. The second elongation factor, EF-Ts, must be able
to bind EF-Tu and catalyze the dissociation of GDP and
the reassociation of GTP [11]. We have shown here that
P. aeruginosa EF-Tu and EF-Ts are active in each of these
functions.
We have also shown for the first time that the presence
of EF-Ts shifts the 𝐾
𝑀
for the interaction of EF-Tu with its
substrate GDP allowing EF-Tu to function at significantly
lower concentrations of GDP. Interestingly, in the absence of
EF-Ts, the 𝐾
𝑀
for the interaction of EF-Tu with GDP was
33 𝜇M. In E. coli, the concentration of GDP is approximately
100 𝜇M [38, 41]. If the concentration of GDP in P. aeruginosa
cells is similar, then a 𝐾
𝑀
of 33 𝜇M would assure that in
P. aeruginosa, EF-Tu would remain bound to GDP after
hydrolysis of GTP to GDP in the ternary complex and before
EF-Ts acts to recycle the EF-Tu to an active state under
physiological conditions. We know that in the absence of
GDP, the sulfhydryl group of a cysteine amino acid in the
GDP/Mg++ binding region interacts with N-ethylmaleimide
(NEM) resulting in complete inactivation of EF-Tu in E. coli
[33]. In the presence of GDP, EF-Tu is not inactivated by
NEM. This indicates that the sulfhydryl group is exposed to
the surroundings and available for contact with an exogenous
entity in the absence of GDP, but in the presence of GDP, no
contact is possible. This cysteine residue in E. coli has been
shown to be Cys137 [46]. In the crystal structure of E. coli
EF-Tu bound to GDP/Mg++, Cys137 is located at the surface
of the protein and near the nucleotide bind region [47].
EF-Tu from P. aeruginosa has no corresponding cysteine at
this position; however, at position 106, there is a cysteine
residue (a valine in E. coli EF-Tu). A cysteine at this position
would be located near Cys137, equally close to the nucleotide
binding site and exposed to the surrounding [47]. Although
inactivation of P. aeruginosa EF-Tu by NEM has not been
shown, this cysteine is a candidate for interaction with NEM.
Once EF-Tu hydrolyzes GTP to GDP during the elongation
stage of protein synthesis, it remains bound tightly to GDP
with a 𝐾GDP in the low nanomolar range. However, as we
have shown dissociation of GDP from EF-Tu occurs to a
certain extent. We suggest that, along with tight binding of
EF-Tu to GDP, having a 𝐾
𝑀
for binding GDP in the range
that we have shownmay be a mechanism of protecting EF-Tu
from inactivation by insuring that it remains bound to GDP.
We have shown that EF-Tu has approximately a sixfold
higher affinity for GDP than for GTP. EF-Tu from different
organisms binds GDP and GTP with affinities that vary
widely. In the E. coli system, EF-Tu binds GDP up to 100-
fold more tightly than it binds GTP [11]. T. thermophilus EF-
Tu has a 10–15-fold higher affinity for GDP than for GTP
[48]. Alternatively, Staphylococcus aureus EF-Tu interacts
with GDP with such a low affinity that it is impossible to
monitor the interaction [49], as does mitochondrial EF-
Tu [50]. However, in all of these organisms, the relative
importance of EF-Ts is to function in recycling of EF-Tu from
an inactive GDP bound state to an active GTP bound state.
EF-Tu from Pseudomonas sp. is all exceptionally similar,
with EF-Tu from P. aeruginosa being ∼90% identical with
all other Pseudomonas sp. EF-Tu proteins. The degree of
homology with EF-Tu from other organisms is also high
(from 60 to 80% identity) with the subtle differences noted
earlier. However, the degree of homology of P. aeruginosa
BioMed Research International 11
EF-Tswith EF-Ts from all other organisms ismuch lower (30–
50%). In particular, the N-terminal and, to a lesser degree,
the C-terminal subdomains of the core region of EF-Ts are
quite diverse. Since these are the two regions that interact
directlywith EF-Tu, it would be of interest in future analysis to
evaluate interactions of P. aeruginosa EF-Ts with EF-Tu from
other organisms.
Conflict of Interests
The authors declare that there is no conflict of interests in this
submitted paper.
Acknowledgments
The authors are grateful for the financial support provided by
the National Institutes of Health (Grant no. 1SC3GM098173-
01A1). Portions of this research were also supported by the
South Texas Border Health Disparities Center (STBHDC)
at the University of Texas-Pan American (UTPA). STBHDC
is funded by a grant from the Centers for Disease Control
and Prevention (Grant 75DP001812). The contents of this
paper are solely the responsibility of the authors and do not
necessarily represent the official views of the Centers for
Disease Control and Prevention or STBHDC. Additionally,
the authors would like to express their gratitude to Dr. Frank
Dean (University of Texas-Pan American) and Dr. Linda
Spremulli (University of North Carolina-Chapel Hill) for
their critical reading of this paper.
References
[1] G. Maschmeyer and I. Braveny, “Review of the incidence
and prognosis of Pseudomonas aeruginosa infections in cancer
patients in the 1990s,” European Journal of Clinical Microbiology
and Infectious Diseases, vol. 19, no. 12, pp. 915–925, 2000.
[2] H. Giamarellou and A. Antoniadou, “Antipseudomonal antibi-
otics,”Medical Clinics of North America, vol. 85, no. 1, pp. 19–42,
2001.
[3] P. Roussel and G. Lamblin, “The glycosylation of airwaymucins
in cystic fibrosis and its relationship with lung infection by
Pseudomonas aeruginosa,” Advances in Experimental Medicine
and Biology, vol. 535, pp. 17–32, 2002.
[4] A. Oliver, R. Canto´n, P. Campo, F. Baquero, and J. Bla´zquez,
“High frequency of hypermutable Pseudomonas aeruginosa in
cystic fibrosis lung infection,” Science, vol. 288, no. 5469, pp.
1251–1253, 2000.
[5] D. F. Sahm, D. C. Draghi, R. N. Master et al., “Pseudomonas
aeruginosa antimicrobial resistance update: US resistance
trends from 1998 to 2001,” p. 91, Proceedings of the 42nd
Interscience Conference on Antimicrobial Agents and Chem-
otherapy (ICAAC ’02), 2002.
[6] S. A. Nouer, M. Pinto, L. Teixeira, and M. Nucci, “Risk factors
formulti-drug resistantPseudomonas aeruginosa (MDRPa) col-
onization or infection in hospitalized patients,” in Proceedings
of the 42nd Interscience Conference on Antimicrobial Agents and
Chemotherapy (ICAAC ’02), p. 340, 2002.
[7] D. J. C. Knowles, N. Foloppe, N. B. Matassova, and A. I.
H. Murchie, “The bacterial ribosome, a promising focus for
structure-based drug design,” Current Opinion in Pharmacol-
ogy, vol. 2, no. 5, pp. 501–506, 2002.
[8] P. Schimmel, J. Tao, and J. Hill, “Aminoacyl tRNA synthetases
as targets for new anti-infectives,” FASEB Journal, vol. 12, no. 15,
pp. 1599–1609, 1998.
[9] R. C. Thompson, D. B. Dix, and A. M. Karim, “The reac-
tion of ribosomes with elongation factor Tu.GTP complexes.
Aminoacyl-tRNA-independent reactions in the elongation
cycle determine the accuracy of protein synthesis,” Journal of
Biological Chemistry, vol. 261, no. 11, pp. 4868–4874, 1986.
[10] M. Sprinzl, “Elongation factor Tu: a regulatory GTPase with an
integrated effector,” Trends in Biochemical Sciences, vol. 19, no.
6, pp. 245–250, 1994.
[11] D. L. Miller and H. Weissbach, “Interactions between the
elongation factors: the displacement of GDP from the Tu-GDP
complex by factor Ts,” Biochemical and Biophysical Research
Communications, vol. 38, no. 6, pp. 1016–1022, 1970.
[12] W. Ribble, W. E. Hill, U. A. Ochsner et al., “Discovery and
analysis of 4H-Pyridopyrimidines, a class of selective bac-
terial protein synthesis inhibitors,” Antimicrobial Agents and
Chemotherapy, vol. 54, no. 11, pp. 4648–4657, 2010.
[13] J. A. Leeds, M. J. LaMarche, J. T. Brewer et al., “In vitro and
in vivo activities of novel, semisynthetic thiopeptide inhibitors
of bacterial elongation factor Tu,” Antimicrobial Agents and
Chemotherapy, vol. 55, no. 11, pp. 5277–5283, 2011.
[14] M. M. K. Jayasekera, K. Onheiber, J. Keith et al., “Identification
of novel inhibitors of bacterial translation elongation factors,”
Antimicrobial Agents and Chemotherapy, vol. 49, no. 1, pp. 131–
136, 2005.
[15] M. F. Tam, J. A. Dodd, and W. E. Hill, “Physical characteristics
of 16 S rRNA under reconstitution conditions,” Journal of
Biological Chemistry, vol. 256, no. 12, pp. 6430–6434, 1981.
[16] M. M. Bradford, “A rapid and sensitive method for the quanti-
tation of microgram quantities of protein utilizing the principle
of protein dye binding,”Analytical Biochemistry, vol. 72, no. 1-2,
pp. 248–254, 1976.
[17] M. G. Cull and C. S. McHenry, “Purification of Escherichia coli
DNApolymerase III holoenzyme,”Methods in Enzymology, vol.
262, pp. 22–35, 1995.
[18] J. G. Grasselli and W. M. Ritchey, “Spectral data and physical
constrants for organic compounds,” in CRC Atlas of Spectral
Data and Physical Constants for Organic Compounds, pp. 387–
390, CRC Press, New York, NY, USA, 1975.
[19] J. M. Bullard, Y.-C. Cai, Y. Zhang, and L. L. Spremulli, “Effects
of domain exchanges between Escherichia coli and mammalian
mitochondrial EF-Tu on interactions with guanine nucleotides,
aminoacyl-tRNA and ribosomes,” Biochimica et Biophysica
Acta, vol. 1446, no. 1-2, pp. 102–114, 1999.
[20] J. M. Ravel, R. L. Shorey, S. Froehner, and W. Shive, “A study
of the enzymic transfer of aminoacyl-RNA to Escherichia coli
ribosomes,”Archives of Biochemistry and Biophysics, vol. 125, no.
2, pp. 514–526, 1968.
[21] A. Louie and F. Jurnak, “Kinetic studies of Escherichia coli elon-
gation factor Tu-guanosine 5󸀠-triphosphate-aminoacyl-tRNA
complexes,” Biochemistry, vol. 24, no. 23, pp. 6433–6439, 1985.
[22] A. Louie, N. S. Ribeiro, B. R. Reid, and F. Jurnak, “Relative
affinities of all Escherichia coli aminoacyl-tRNAs for elongation
factor Tu-GTP,” Journal of Biological Chemistry, vol. 259, no. 8,
pp. 5010–5016, 1984.
[23] J. M. Bullard, J. C. Williams, W. K. Acker, C. Jacobi, N. Janjic,
and C. S. McHenry, “DNA polymerase III holoenzyme from
12 BioMed Research International
Thermus thermophilus identification, expression, purification
of components, and use to reconstitute a processive replicase,”
Journal of Biological Chemistry, vol. 277, no. 16, pp. 13401–13408,
2002.
[24] D. Kavaliauskas, P. Nissen, and C. R. Knudsen, “The busiest of
all ribosomal assistants: elongation factor Tu,”Biochemistry, vol.
51, no. 13, pp. 2642–2651, 2012.
[25] I. M. Krab and A. Parmeggiani, “EF-Tu, a GTPase odyssey,”
Biochimica et Biophysica Acta, vol. 1443, no. 1-2, pp. 1–22, 1998.
[26] T. Kawashima, C. Berthet-Colominas, M.Wulff, S. Cusack, and
R. Leberman, “The structure of the Escherichia coli EF-Tu.EF-
Ts complex at 2.5 A˚ resolution,” Nature, vol. 379, no. 6565, pp.
511–518, 1996.
[27] H. Berchtold, L. Reshetnikova, C. O. A. Reiser, N. K. Schirmer,
M. Sprinzl, and R. Hilgenfeld, “Crystal structure of active
elongation factor Tu reveals major domain rearrangements,”
Nature, vol. 365, pp. 126–132, 1993.
[28] O. Wiborg, C. Andersen, C. R. Knudsen, T. J. Kristensen, and
B. F. Clark, “Towards an understanding of structure-function
relationships of elongation factorTu,”Biotechnology andApplied
Biochemistry, vol. 19, p. 1, 1994.
[29] P. Nissen, M. Kjeldgaard, S. Thirup et al., “Crystal structure
of the ternary complex of Phe-tRNA(Phe), EF-Tu, and a GTP
analog,” Science, vol. 270, no. 5241, pp. 1464–1472, 1995.
[30] Y. Jiang, S. Nock, M. Nesper, M. Sprinzl, and P. B. Sigler,
“Structure and importance of the dimerization domain in
elongation factor Ts fromThermus thermophilus,” Biochemistry,
vol. 35, no. 32, pp. 10269–10278, 1996.
[31] M. G. Jeppesen, T. Navratil, L. L. Spremulli, and J. Nyborg,
“Crystal structure of the bovine mitochondrial elongation
factor Tu.Ts complex,” Journal of Biological Chemistry, vol. 280,
no. 6, pp. 5071–5081, 2005.
[32] Y. Zhang, V. Sun, and L. L. Spremulli, “Role of domains
in Escherichia coli and mammalian mitochondrial elongation
factor ts in the interaction with elongation factor Tu,” Journal
of Biological Chemistry, vol. 272, no. 35, pp. 21956–21963, 1997.
[33] D. L. Miller and H. Weissbach, “Studies on the purification and
properties of factor Tu from E. coli,” Archives of Biochemistry
and Biophysics, vol. 141, no. 1, pp. 26–37, 1970.
[34] D. L. Miller and H. Weissbach, “Elongation factor Tu and the
aminoacyl-tRNA-EFTu-GTP complex,” Methods in Enzymol-
ogy, vol. 30, pp. 219–232, 1974.
[35] Y.-C. Cai, J. M. Bullard, N. L. Thompson, and L. L. Spremulli,
“Interaction of mammalian mitochondrial elongation factor
EF-Tu with guanine nucleotides,” Protein Science, vol. 9, no. 9,
pp. 1791–1800, 2000.
[36] H. Weissbach, B. Redfield, and N. Brot, “Further studies on
the role of factors Ts and Tu in protein synthesis,” Archives of
Biochemistry and Biophysics, vol. 144, no. 1, pp. 224–229, 1971.
[37] V. Chau, G. Romero, and R. L. Biltonen, “Kinetic studies on the
interactions of Escherichia coli K12 elongation factor Tu with
GDP and elongation factor Ts,” Journal of Biological Chemistry,
vol. 256, no. 11, pp. 5591–5596, 1981.
[38] Y.-C. Cai, J. M. Bullard, N. L. Thompson, and L. L. Spremulli,
“Interaction of mitochondrial elongation factor Tu with
aminoacyl-tRNA and elongation factor Ts,” Journal of Biological
Chemistry, vol. 275, no. 27, pp. 20308–20314, 2000.
[39] Y.W.Hwang andD. L.Miller, “A study of the kineticmechanism
of elongation factor Ts,” Journal of Biological Chemistry, vol. 260,
no. 21, pp. 11498–11502, 1985.
[40] Y.-X. Zhang, J. Tao, M. Zhou et al., “Elongation factor Ts of
Chlamydia trachomatis: structure of the gene and properties of
the protein,” Archives of Biochemistry and Biophysics, vol. 344,
no. 1, pp. 43–52, 1997.
[41] B. R. Bochner and B. N. Ames, “Complete analysis of cellular
nucleotides by two-dimensional thin layer chromatography,”
Journal of Biological Chemistry, vol. 257, no. 16, pp. 9759–9769,
1982.
[42] K. B. Gromadski, H.-J. Wieden, and M. V. Rodnina, “Kinetic
mechanism of elongation factor Ts-catalyzed nucleotide
exchange in elongation factor Tu,” Biochemistry, vol. 41, no. 1,
pp. 162–169, 2002.
[43] K. L. Manchester, “Determination of the kinetics of guanine
nucleotide exchange onEF-Tu andEF-Ts: continuing uncertain-
ties,” Biochemical and Biophysical Research Communications,
vol. 314, no. 1, pp. 1–5, 2004.
[44] F. Jurnak, S. Heffron, B. Schick, and K. Delaria, “Three-
dimensional models of the GDP and GTP forms of the guanine
nucleotide domain of Escherichia coli elongation factor Tu,”
Biochimica et Biophysica Acta, vol. 1050, no. 1–3, pp. 209–214,
1990.
[45] A. Pingoud, C. Urbanke, G. Krauss, F. Peters, and G. Maass,
“Ternary complex formation between elongation factor Tu,
GTP and aminoacyl-tRNA: an equilibrium study,” European
Journal of Biochemistry, vol. 78, no. 2, pp. 403–409, 1977.
[46] S. Nakamura, K. Arai, K. Takahashi, and Y. Kaziro, “Alignment
of the tryptic fragments and location of sulfhydryl groups of
the polypeptide chain elongation factor Tu,” Biochemical and
Biophysical Research Communications, vol. 77, no. 4, pp. 1418–
1424, 1977.
[47] H. Song, M. R. Parsons, S. Rowsell, G. Leonard, and S. E.
V. Phillips, “Crystal structure of intact elongation factor EF-
Tu from Escherichia coli in GDP conformation at 2.05 A˚
resolution,” Journal of Molecular Biology, vol. 285, no. 3, pp.
1245–1256, 1999.
[48] A. Wagner, I. Simon, M. Sprinzl, and R. S. Goody, “Interaction
of guanosine nucleotides and their analogs with elongation
factor Tu fromThermus thermophilus,”Biochemistry, vol. 34, no.
39, pp. 12535–12542, 1995.
[49] C. C. Hall, J. D. Watkins, and N. H. Georgopapadakou, “Com-
parison of the Tu elongation factors from Staphylococcus aureus
and Escherichia coli: possible basis for elfamycin insensitivity,”
Antimicrobial Agents and Chemotherapy, vol. 35, no. 11, pp.
2366–2370, 1991.
[50] C. J. Schwartzbach and L. L. Spremulli, “Bovine mitochondrial
protein synthesis elongation factors. Identification and initial
characterization of an elongation factor Tu-elongation factor Ts
complex,” Journal of Biological Chemistry, vol. 264, no. 32, pp.
19125–19131, 1989.
